O

ONCOSITE Centro de Pesquisa Clinica em Oncologia | Ijui, Brazil

Research site

(Unclaimed)

Location

618 Sao Cristovao St., Hammarstron, Ijuí, Rio Grande do Sul, Brazil

Site insights

Top conditions

Top treatments

Pembrolizumab

BGB-43395

Letrozole

BNT327

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 4 total trials

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

The primary objective of this trial is to demonstrate pharmacokinetic (PK) similarity of ABP 234 compared with the pembrolizumab reference product (K...

Active, not recruiting

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Drug: ABP 234

Drug: Pembrolizumab (EU)

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease (KANDELA-302)

The purpose of this study is to investigate the efficacy and safety of BGB-43395 in combination with letrozole compared with investigator's choice of...

Enrolling

HR+/HER2- Breast Cancer

Drug: Palbociclib

Drug: Letrozole

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

This is a Phase 2/3, multisite, randomized, open-label study in participants with first-line non-small cell lung cancer (NSCLC).This study includes t...

Enrolling

Non-small Cell Lung Cancer

Drug: Pembrolizumab

Drug: Paclitaxel

Trial sponsors

B

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms